血造干细胞移植用于免疫系统的先天性缺陷-谁和什么时候?
Joseph H Oved1, Rebecca A Marsh2,3,4, Aleksandra Petrovic5
1Transplant and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
British journal of haematology
|July 7, 2025
概括
异性造血干细胞移植可以治愈免疫的先天性错误 (IEI). 本文回顾了影响IEI患者接受这种最终治疗的治疗决定的因素.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 移植医学 移植医学
背景情况:
- 全基性造血细胞移植 (HCT) 是一种潜在的治愈选择,用于免疫的先天性错误 (IEI).
- HCT涉及重大并发症和毒性,必须仔细考虑.
- 对IEI患者的治疗决定需要对风险和益处进行彻底的评估.
研究的目的:
- 讨论影响IEI患者最终治疗决策的关键因素.
- 在IEI管理的背景下,提供对HCT考虑的简要概述.
主要方法:
- 审查当前的文献和临床指南.
- 讨论影响HCT候选性的患者特定因素.
- 对IEI与HCT相关的潜在并发症和长期结果的分析.
主要成果:
- 最终的治疗决定是多因素的,涉及疾病的严重程度,捐赠者的可用性和患者的并发症.
- 风险分层和仔细的患者选择对于优化IEI中HCT结果至关重要.
- 了解潜在的毒性和长期后果对于明智的决策至关重要.
结论:
- HCT为严重的IEI提供了一个有前途的治疗途径,但需要仔细规划.
- 临床医生和患者之间的共同决策至关重要.
- 正在进行的研究对于进一步完善HCT协议和改善IEI患者的治疗结果至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
504
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
504
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Tissue Transplantation
524
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K


